QUINCE THERAPEUTICS, INC. (QNCX) Technical Analysis

🔺 Technical Setup

🎯 Decision Map

From a roadmap perspective, the setup is boxed by support near 0.80 and resistance around 3.52. The chart still needs to reclaim resistance to improve meaningfully, while any loss of support would keep weakness in control.

📊 Technical Summary

QUINCE THERAPEUTICS, INC. (QNCX) closed at 1.31 (+6.50%). Price has recovered above the 50-day average but remains below the 200-day average, so the short-term tone is improving while the larger structure is still rebuilding. 20-day momentum is notably strong at +28.43%; price is trading in the lower part of its roughly 52-week range (0.80–44.00); and ATR14 volatility is elevated at roughly 11.99% of price. RSI(14) stands around 43.6, which keeps the momentum picture broadly balanced. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD is positioned above the signal line, supporting a still constructive momentum backdrop. The MACD histogram remains positive, although upside momentum is not accelerating further. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. The nearest decision zone is framed by support at 0.80 and resistance at 3.52. A move through resistance would improve the short-term technical tone, while a loss of support would weaken the current structure. Latest fundamentals snapshot: Net income: -83.98M · EPS (basic): -0.25. The interactive view adds overlays, pattern context and broader chart structure for deeper review.

Explore more